The use of trusted tools by our analyst has helped them conclude the market size of the global Dental Anticoagulants market in terms of USD Million during the forecast timeframe. The report showcases the historic data from 2016 to 2019 along with the forecast data from 2020 to 2026. The market research study provides the market statistics and drivers that help the market expand in a graphical and theoretical pattern.
Our experts have used some of the best tools like Porter’s Five Forces, PESTEL analysis, and SWOT analysis to study market trends and challenges. These tools also help study each and every microscopic data that has an impact on market growth. The market-oriented study offers all the details such as mergers, joint ventures, market share, market statistics, emerging trends, challenges & opportunities, and new launches.
Anticoagulant drugs are commonly referred to as blood thinners. These are chemical substances that help prevent or lower coagulation of blood and instead increase blood clotting time. Anticoagulant drugs are primarily used in case of chronic medical conditions with a higher risk of blood clots. Anticoagulant drugs such as the direct anticoagulants are generally used during dental invasive treatments and surgeries.
The growing occurrence of severe disorders such as diabetes, cardiovascular diseases, cancer, etc. along with technological innovations is likely to surge the Dental Anticoagulants market. In addition, the increasing expenditure on research and development will further supplement the growth of the market. The rising number of the older population, high labor costs, and high supply & demand will further propel the market during the forecast timeframe. Likewise, growing healthcare awareness and disposable income are anticipated to drive the market growth.
Direct oral anticoagulants (DOACs) are widely used anticoagulants due to their easy use and excellent safety profile. They have set doses and do not require regular international standardizations. Thus, the high demand for DOACs owing to their safety is expected to drive the global Dental Anticoagulants market over the forecast period. The novel alternative anticoagulants are expected to open new doors of opportunities for the Dental Anticoagulants market. However, the risks associated with the use of anticoagulant and stringent regulatory requirements are the major market restraints.
Based on drug class, the market for dental anticoagulants is segregated into DOACs, Vitamin K Antagonist, Heparin, and Others. On the basis of route of administration, the global Dental Anticoagulants market is divided into Oral Anticoagulants and Injectable Anticoagulants. In terms of distribution channel, the market is categorized into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
Some of the key players in the global Dental Anticoagulants market are Daiichi Sankyo Company, Limited, Sanofi S.A, Aspen Holdings, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Pfizer, Inc., Abbott, Portola Pharmaceuticals, Inc., and Mylan N.V.
The global Dental Anticoagulants market is segmented into:
Global Dental Anticoagulants Market: By Drug Class
Global Dental Anticoagulants Market: By Route of Administration
Global Dental Anticoagulants Market: By Distribution Channel
Global Dental Anticoagulants Market: By Region
Key Pointers Addressed by the Report
Table of Content
Key Insights from Primary Research
Key Recommendations from Analysts
Market Attractiveness in 2018: By Drug Class
Industry Major Market Players